Qi Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Gut microbiota and health
Papers in
-
- Cancer-related molecular mechanisms research 28
- Cancer, Hypoxia, and Metabolism 17
- MicroRNA in disease regulation 11
- Co-authors
- Qing JiLihong ZhouHua SuiYan WangXiaoting SunJianfeng CaiJing ZhouYuanyuan Feng
- Journals
- Frontiers in Pharmacology (7 papers)Journal of Medicinal Chemistry (7 papers)Journal of Ethnopharmacology (6 papers)Biomedicine & Pharmacotherapy (5 papers)Oncology Reports (5 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Qi Li
201 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 149
- Cancer Research 1.7k
- Molecular Biology 3.5k
- Complementary and alternative medicine 361
- Biological Psychiatry 100
- Pharmacology 319
Countries citing papers authored by Qi Li
This map shows the geographic impact of Qi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Li more than expected).
Fields of papers citing papers by Qi Li
This network shows the impact of papers produced by Qi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Li. The network helps show where Qi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 2 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 11 | |
| 12 | 2019 | 69 | |
| 13 | Correlation Between Chemical Constituents and Ecological Factors of Tibetan Medicine Swertia mussotii | 2019 | 0 |
| 14 | 2019 | 1 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 96 | |
| 17 | Clinical research on treating metastatic colorectal cancer with Jianpi Jiedu Decoction and chemotherapy | 2015 | 3 |
| 18 | Effect of Tanshinone II_A on Angiogenesis in Nude Mice with Colorectal Cancer | 2013 | 1 |
| 19 | Effect of Tanshinone II A on COX-2-β-catenin signal transduction pathway-mediated VEGF expression in human colorectal cancer cells | 2013 | 2 |
| 20 | Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model. | 2006 | 14 |
About Qi Li
Qi Li is a scholar working on Cancer Research, Complementary and alternative medicine, Pharmacology, Biological Psychiatry and Molecular Biology, having authored 206 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (28 papers), Autophagy in Disease and Therapy (19 papers), Cancer, Hypoxia, and Metabolism (17 papers), RNA modifications and cancer (13 papers), Gut microbiota and health (12 papers), Epigenetics and DNA Methylation (12 papers), MicroRNA in disease regulation (11 papers) and Pharmacological Effects of Natural Compounds (9 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (3.5k citations), Complementary and alternative medicine (361 citations), Biological Psychiatry (100 citations) and Pharmacology (319 citations). Qi Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Qing Ji, Lihong Zhou, Hua Sui, Yan Wang, Xiaoting Sun, Jianfeng Cai, Jing Zhou, Yuanyuan Feng, Peihao Yin and Ningning Liu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Medicinal Chemistry, Journal of Ethnopharmacology, Biomedicine & Pharmacotherapy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.